Negotiating the Price of Drugs
Negotiating the Price of Drugs In August 2022, President Biden signed the Inflation Reduction Act, which gave Medicare the authority to negotiate drug prices for the first time in history. Politicians are taking a victory lap. The truth is the pharmaceutical industry could take a victory lap. In this article, I will take a look […]
Corrupt Congress
Congress not only indirectly raised the cost of healthcare by not allowing Medicare to negotiate drug prices, but also in at least one case, it raised the cost of drugs through a pinpoint piece of legislation. The New York Times reported a provision buried in the “fiscal cliff” bill passed in January 2013 gave Amgen, […]
Drug Makers Putting Profit Before The Elderly
The Medpage Today staff reported this week on a CNN investigation of Nuedexta, a drug approved for PseudoBulbar Affect (PBA). The investigation found PBA is being marketed aggressively to the elderly as a therapy for dementia. Even though independent studies indicate PBA is only rarely associated with dementia, Avanir, the drug’s manufacturer, has spent millions of dollars promoting […]
Congress Puts Drug Lobbyists Ahead of Those They are Supposed to Represent
As I have written in Health Attitude: Unraveling and Solving the Complexities of Healthcare, there are many problems with the American healthcare system. The number one problem is the high cost. It is not the cost of the insurance, it is the cost of delivering the healthcare. Billions of dollars are spent on legal fees to […]
